Gefticip 250 mg Tablet
  1. Home
  2. Pharma Products
  3. Cipla Ltd
  4. Gefticip 250 mg Tablet

Gefticip 250 mg Tablet

Gefticip 250 mg Tablet contains gefitinib 250 mg, a targeted anticancer medicine used for certain types of non-small cell lung cancer. It is an oral tablet taken according to the treatment plan prescribed by the oncologist. Gefitinib works by blocking EGFR tyrosine kinase activity, which can help slow the growth of cancer cells.

BUY NOW

Category

Gefticip 250 mg Tablet is used for non-small cell lung cancer in patients with specific activating EGFR mutations. Gefitinib belongs to the epidermal growth factor receptor tyrosine kinase inhibitor class and interferes with signaling pathways involved in cancer-cell growth. The dose and duration of treatment are determined by the treating oncologist according to the patient’s condition and treatment response. Regular medical follow-up may be required to monitor treatment effectiveness and possible adverse effects.

Technical Specification

Specification Details
Active Ingredient Gefitinib
Strength 250 mg
Dosage Form Tablet
Route of Administration Oral
Pack Size 10 Tablets / 30 Tablets
Manufacturer Cipla Ltd.

Product Also Known As

Gefticip 250 mg Tablet, Gefticip 250 Tablet, Gefticip Gefitinib Tablet, Gefitinib 250 mg Tablet, Gefitinib EGFR Inhibitor Tablet, Gefitinib Lung Cancer Tablet